These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 31175392)

  • 1. The role of inflammation in diabetic eye disease.
    Mesquida M; Drawnel F; Fauser S
    Semin Immunopathol; 2019 Jul; 41(4):427-445. PubMed ID: 31175392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
    Garcia-Ramírez M; Hernández C; Palomer X; Vázquez-Carrera M; Simó R
    Acta Diabetol; 2016 Feb; 53(1):109-18. PubMed ID: 25936740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystoid edema, neovascularization and inflammatory processes in the murine Norrin-deficient retina.
    Beck SC; Karlstetter M; Garcia Garrido M; Feng Y; Dannhausen K; Mühlfriedel R; Sothilingam V; Seebauer B; Berger W; Hammes HP; Seeliger MW; Langmann T
    Sci Rep; 2018 Apr; 8(1):5970. PubMed ID: 29654250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.
    Bosma EK; van Noorden CJF; Schlingemann RO; Klaassen I
    Fluids Barriers CNS; 2018 Sep; 15(1):24. PubMed ID: 30231925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature.
    Zhang C; Lai MB; Pedler MG; Johnson V; Adams RH; Petrash JM; Chen Z; Junge HJ
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2691-2705. PubMed ID: 30354230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage.
    D'Amico AG; Maugeri G; Rasà D; Federico C; Saccone S; Lazzara F; Fidilio A; Drago F; Bucolo C; D'Agata V
    J Cell Physiol; 2019 Apr; 234(4):5230-5240. PubMed ID: 30374973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and pharmacological targets of VEGF in diabetic macular edema.
    Fogli S; Mogavero S; Egan CG; Del Re M; Danesi R
    Pharmacol Res; 2016 Jan; 103():149-57. PubMed ID: 26607863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown.
    Kuo C; Green CR; Rupenthal ID; Mugisho OO
    Acta Diabetol; 2020 Jan; 57(1):13-22. PubMed ID: 31030263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.
    Noma H; Yasuda K; Shimura M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.
    Desjardins DM; Yates PW; Dahrouj M; Liu Y; Crosson CE; Ablonczy Z
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2706-13. PubMed ID: 27191823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.
    Sodhi A; Ma T; Menon D; Deshpande M; Jee K; Dinabandhu A; Vancel J; Lu D; Montaner S
    J Clin Invest; 2019 Nov; 129(11):4593-4608. PubMed ID: 31545295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the retinal pigment epithelium (RPE) in the pathogenesis and treatment of diabetic macular edema (DME)].
    Chmielewska K; Robaszkiewicz J; Kosatka M
    Klin Oczna; 2008; 110(7-9):318-20. PubMed ID: 19112870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
    Urias EA; Urias GA; Monickaraj F; McGuire P; Das A
    Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy?
    van der Wijk AE; Hughes JM; Klaassen I; Van Noorden CJF; Schlingemann RO
    J Leukoc Biol; 2017 Oct; 102(4):993-1001. PubMed ID: 28724696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological mechanisms in the pathogenesis of diabetic retinopathy.
    Adamis AP; Berman AJ
    Semin Immunopathol; 2008 Apr; 30(2):65-84. PubMed ID: 18340447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier.
    Ouyang H; Mei X; Zhang T; Lu B; Ji L
    Eur J Pharmacol; 2018 Dec; 840():20-27. PubMed ID: 30268667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
    Pruneau D; Bélichard P; Sahel JA; Combal JP
    Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.
    Altmann C; Schmidt MHH
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of puerarin against IL-1β-mediated leukostasis and apoptosis in retinal capillary endothelial cells (TR-iBRB2).
    Zhu X; Xie M; Wang K; Zhang K; Gao Y; Zhu L; Zhou F
    Mol Vis; 2014; 20():1815-23. PubMed ID: 25593509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.